KalVista Pharmaceuticals said on Monday the U.S. Food and Drug Administration has approved its drug, Ekterly, for a type of ...

Reduced monthly costs for uninsured patients still amount to around $500. That can put the drugs out of reach for many.

Regeneron Pharmaceuticals’ Lynozyfic (linvoseltamab-gcpt) has been granted accelerated approval by the US Food and Drug ...

KalVista Pharmaceuticals shares jumped in premarket trading Monday after the company said it has received regulatory approval for its treatment of hereditary angioedema. Shares traded 20% higher ahead ...

Shares of Cogent Biosciences were higher after the company disclosed what it called positive top-line results from a recent trial of its treatment for certain types of mastocytosis, a rare disorder in ...

Due to health concerns, animal welfare, or safety regulations, certain foods that are considered delicacies in other countries are banned within U.S. borders. Some of these items are prohibited due to ...

Mumbai, July 7: Maharashtra Rural Development Minister Jaikumar Gore on Monday in the state council announced the suspension ...

Exclusive agreement includes over $70 million in upfront and milestone payments to LENZ in addition to double-digit royalties ...